Should multivisceral transplantation be considered in patients colonized with multidrug-resistant Pseudomonas aeruginosa?

Microbial Drug Resistance

Volumn 18, Issue 1, 2012, Pages 74-78

  Florescu, Diana F ^a   Grant, Wendy ^a   Botha, Jean F ^a   Fey, Paul ^b   Kalil, Andre C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL COLONIZATION; CASE REPORT; FEMALE; HUMAN; INTESTINE TRANSPLANTATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; MULTIDRUG RESISTANCE; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PEDIATRIC SURGERY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SHORT BOWEL SYNDROME;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CHILD, PRESCHOOL; DISEASE MANAGEMENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FLUCONAZOLE; HUMANS; INTESTINE, SMALL; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84856692171     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0099     Document Type: Article

References (24)

1. Dobbin, C., M. Maley, J. Harkness, R. Benn, M. Malouf, A. Glanville, and P. Bye. 2004. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J. Hosp. Infect. 56:277-282. (Pubitemid 38444079)
2. Dunham, S.A., C.J. McPherson, and A.A. Miller. 2010. The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 29:279-288.
3. Giamarellos-Bourboulis, E.J., H. Sambatakou, I. Galani, and H. Giamarellou. 2003. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. J. Chemother. 15:235-238. (Pubitemid 36819310)
4. Hadjiliadis, D., M.P. Steele, C. Chaparro, L.G. Singer, T.K. Waddell, M.A. Hutcheon, R.D. Davis, D.E. Tullis, S.M. Palmer, and S. Keshavjee. 2007. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J. Heart Lung Transplant 26:834-838. (Pubitemid 47199077)
5. Imamura, Y., Y. Higashiyama, K. Tomono, K. Izumikawa, K. Yanagihara, H. Ohno, Y. Miyazaki, Y. Hirakata, Y. Mizuta, J. Kadota, B.H. Iglewski, and S. Kohno. 2005. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob. Agents Chemother. 49:1377-1380. (Pubitemid 40463365)
6. Kanellakopoulou, K., P. Sarafis, I. Galani, H. Giamarellou, and E.J. Giamarellos-Bourboulis. 2008. In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 32:33-39.
7. Landman, D., S. Bratu, M. Alam, and J. Quale. 2005. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. J. Antimicrob. Chemother. 55:954-957. (Pubitemid 40883181)
8. Livermore, D.M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640. (Pubitemid 34165326)
9. Meachery, G., A. De Soyza, A. Nicholson, G. Parry, A. Hasan, K. Tocewicz, T. Pillay, S. Clark, J.L. Lordan, S. Schueler, A.J. Fisher, J.H. Dark, F.K. Gould, and P.A. Corris. 2008. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 63:725-731.
10. Nagino, K., and H. Kobayashi. 1997. Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa. Clin. Microbiol. Infect. 3:432-439. (Pubitemid 27379981)
11. Nalca, Y., L. Jansch, F. Bredenbruch, R. Geffers, J. Buer, and S. Haussler. 2006. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob. Agents Chemother. 50:1680-1688.
12. Nguyen, D., M.J. Emond, N. Mayer-Hamblett, L. Saiman, B.C. Marshall, and J.L. Burns. 2007. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes. Pediatr. Pulmonol. 42:533-541. (Pubitemid 46870385)
13. Pankuch, G.A., G. Lin, H. Seifert, and P.C. Appelbaum. 2008. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob. Agents Chemother. 52:333-336.
14. Reinhardt, A., T. Kohler, P. Wood, P. Rohner, J.L. Dumas, B. Ricou, and C. van Delden. 2007. Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients. Antimicrob. Agents Chemother. 51:1341-1350. (Pubitemid 46586815)
15. Rhomberg, P.R., and R.N. Jones. 2009. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). Diagn. Microbiol. Infect. Dis. 65:414-426.
16. Strateva,T., and D. Yordanov. 2009. Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J. Med. Microbiol. 58:1133-1148.
17. Tamaoki, J. 2004. The effects of macrolides on inflammatory cells. Chest. 125:41S-50S; quiz 51S.
18. Tan, T.Y., and S.Y. Ng. 2006. The in-vitro activity of colistin in gram-negative bacteria. Singapore Med. J. 47:621-624. (Pubitemid 44048976)
19. Tsai, W.C., M.L. Rodriguez, K.S. Young, J.C. Deng, V.J. Thannickal, K. Tateda, M.B. Hershenson, and T.J. Standiford. 2004. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am. J. Respir. Crit. Care Med. 170:1331-1339. (Pubitemid 39657198)
20. Turner, P.J. 2009. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates. Diagn. Microbiol. Infect. Dis. 63:217-222.
21. van Delden, C., E.A. Blumberg, and AST Infectious Diseases Community of Practice. 2009. Multidrug resistant gram-negative bacteria in solid organ transplant recipients. Am. J. Transplant. 9(Suppl. 4):S27-S34.
22. Visalli, M.A., M.R. Jacobs, and P.C. Appelbaum. 1998. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology. Antimicrob. Agents Chemother. 42:953-955. (Pubitemid 28216390)
23. Wagner, T., G. Soong, S. Sokol, L. Saiman, and A. Prince. 2005. Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. Chest 128: 912-919. (Pubitemid 41140526)
24. Yamasawa, H., K. Oshikawa, S. Ohno, and Y. Sugiyama. 2004. Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colonystimulating factor release. Am. J. Respir. Cell Mol. Biol. 30:569-575. (Pubitemid 38457190)